[go: up one dir, main page]

CN1170549C - Process for preparing 'Qianjin' capsule to treat genopathy - Google Patents

Process for preparing 'Qianjin' capsule to treat genopathy Download PDF

Info

Publication number
CN1170549C
CN1170549C CNB99115682XA CN99115682A CN1170549C CN 1170549 C CN1170549 C CN 1170549C CN B99115682X A CNB99115682X A CN B99115682XA CN 99115682 A CN99115682 A CN 99115682A CN 1170549 C CN1170549 C CN 1170549C
Authority
CN
China
Prior art keywords
clear paste
radix
root
water
extracted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB99115682XA
Other languages
Chinese (zh)
Other versions
CN1298730A (en
Inventor
左之文
陈红英
王振勇
龚云
刘兰芝
龙福莲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhuzhou Qianjin Pharmaceutical Co Ltd
Original Assignee
Zhuzhou Qianjin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhuzhou Qianjin Pharmaceutical Co Ltd filed Critical Zhuzhou Qianjin Pharmaceutical Co Ltd
Priority to CNB99115682XA priority Critical patent/CN1170549C/en
Publication of CN1298730A publication Critical patent/CN1298730A/en
Application granted granted Critical
Publication of CN1170549C publication Critical patent/CN1170549C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a 'Qianjin' capsule for treating gynecopathy, which is prepared from moghania, cherokee rose root, common andrographis herb, Chinese angelica root, leatherleaf mahonia, spatholobus stem and pilose asiabell root as raw materials. The present invention has the preparation process that firstly, the Chinese angelica root and the common andrographis herb are extracted by alcohol to obtain clear paste; after the leatherleaf mahonia and Dianmianzhen are boiled in water twice, filter liquor is made into clear paste; the moghania, the cherokee rose root, the spatholobus stem and the pilose asiabell root are boiled in water to obtain filter liquor; the dregs of the moghania, the cherokee rose root, the spatholobus stem and the pilose asiabell root, the dregs of the Chinese angelica root and the dregs of the common andrographis herb are boiled in water; all the filter liquor is mixed to obtain clear paste; finally, four kinds of clear paste are processed through the working procedures of mixing uniformly, spray drying, granulating and filling to obtain the 'Qianjin' capsule for treating gynecopathy.

Description

A kind of FUKE QIANJIN JIAONANG
The present invention relates to a kind of FUKE QIANJIN JIAONANG, belong to the Chinese medicinal capsule preparation.
China's Chinese medicine generally all adopts decoction, pill, powder etc.; Later on along with tablet has appearred again in society's science and technology, economic progress.FUKE QIANJIN PIAN is to be raw material with Chinese crude drug Radix Flemingiae Philippinensis, Radix Rosae Laevigatae, Herba Andrographis, Radix Angelicae Sinensis, Caulis Mahoniae, Fructus Zanthoxyli Dissiti, Caulis Spatholobi and Radix Codonopsis, through the tablet form compound Chinese patent medicine of selecting materials, pulverizing, operation such as granulation, coating being made.Clinical practice through has for many years shown that it is a kind of a kind of cheap and good-quality good medicine that is applicable to gynaecopathias such as woman uterus inflammation, urgent chronic pelvic inflammatory disease, endometritis, menoxenia, leucorrhoea grow in quantity really.
The Chinese patent medicine FUKE QIANJIN PIAN is a kind of rare gynecological's good medicine, but it still exists some shortcomings of Chinese patent medicine tablet: dose is bigger, will eat 6 at every turn; Patient is when taking this tablet, though eaten into the active ingredient that it works the effect of curing the disease, the adjuvant of in fact also having eaten into fiber such as quite a few plant roots that contains these medicine active ingredients, stem, leaf and invalid element simultaneously and having added in production process.Patient is after taking medicine, and some active ingredient can not fully be digested and assimilated and excrete thereupon by the intestines and stomach; And patient is after taking medicine, and tablet disintegration time under one's belt is long, it is slow or the like to take effect.So how to improve the bioavailability of Chinese medicine, active ingredient is fully extracted, improving curative effect of medication is the developing direction of Chinese patent medicine, capsule then is one of its correct selection path.
Purpose of the present invention aims to provide the requirement of a kind of adaptation FUKE QIANJIN PIAN compatibility, can make the capsule of its performance optimum curative effect.
This FUKE QIANJIN JIAONANG is characterized in that: it is with following raw materials according, makes according to following method, and raw material: the incorporation of Radix Angelicae Sinensis, Radix Codonopsis, Herba Andrographis and Fructus Zanthoxyli Dissiti respectively is 9% of a medical material total amount; The incorporation of Fructus Rosae Laevigatae silver, Caulis Spatholobi, Caulis Mahoniae and Radix Flemingiae Philippinensis respectively is 16% of a medical material total amount, method: A, at first Radix Angelicae Sinensis is extracted with alcohol percolation method makes clear paste; B, Herba Andrographis extracted with ethanol refluxing process make clear paste; C, Caulis Mahoniae, Fructus Zanthoxyli Dissiti decocting in water are extracted twice, after filtering the merging of both filtrates is made clear paste; D, Radix Flemingiae Philippinensis, Radix Rosae Laevigatae, Caulis Spatholobi, Radix Codonopsis decocting in water are extracted an after-filtration, the medicinal residues after the filter with the Radix Angelicae Sinensis medicinal residues of technology A and the Herba Andrographis medicinal residues decocting in water of technology B, are filtered, merging filtrate is also made clear paste; E, merge above-mentioned A, B, four kinds of clear paste of C, D, through mixing, spray drying, granulation, fill four procedures the finished product FUKE QIANJIN JIAONANG.
According to the FUKE QIANJIN JIAONANG that above-mentioned process program is produced, to compare with the FUKE QIANJIN PIAN that has circulated at present the city, its advantage is to make the active ingredient extraction in the medical material more abundant, the relative enrichment of active ingredient; Simultaneously medicine disintegration time under one's belt shortens, and has eliminated former mixing and has contained the invalid thing in the Herba Andrographis and Radix Angelicae Sinensis in the FUKE QIANJIN PIAN, and patient's drug administration amount is reduced, and improves the curative effect instant effect.
Below provide embodiment, and further set forth the present invention in conjunction with the embodiments:
Prescription according to the compound women's QIANJIN PIAN: the incorporation of Radix Angelicae Sinensis, Radix Codonopsis, Herba Andrographis and Fructus Zanthoxyli Dissiti respectively is 9% of a medical material gross weight; The incorporation of Radix Rosae Laevigatae, Caulis Spatholobi, Caulis Mahoniae and Radix Flemingiae Philippinensis respectively is 16% of a medical material total amount.Then, at first Radix Angelicae Sinensis is extracted with alcohol percolation method and make clear paste according to above-mentioned process; Secondly Herba Andrographis is extracted with ethanol refluxing process and make clear paste; It three is that Caulis Mahoniae, Fructus Zanthoxyli Dissiti decocting in water are extracted twice, after filtering twice filtrate merging is made clear paste; It four is with Radix Flemingiae Philippinensis, Radix Rosae Laevigatae, Caulis Spatholobi, after-filtration of Radix Codonopsis decocting in water, and the medicinal residues after the filter with the Radix Angelicae Sinensis medicinal residues of technology A and the Herba Andrographis medicinal residues decocting in water of technology B, are filtered and merge two filtrates and also make clear paste; It five is to merge above-mentioned four kinds of clear paste, through mixing, spray drying, granulation, fill four procedures FUKE QIANJIN JIAONANG.
In above-mentioned operation, what really play effect is that above-mentioned all medical materials are adopted the method for extracting of handling respectively; Experiment through this programme inventor: adopt the difference decocting in water extracting method of Radix Rosae Laevigatae, Radix Flemingiae Philippinensis and Caulis Mahoniae and Fructus Zanthoxyli Dissiti, extract than decocting in water that above-mentioned four kinds of medical materials are mixed, the content of tannin and berberine exceeds 2.5~5 times respectively in its filtrate.
The result shows through zoopery: FUKE QIANJIN JIAONANG all has the obvious suppression effect to rat paw edema due to Oleum Tiglii induced mice ear swelling, the chondrus ocellatus Holmes and rat cotton balls granuloma.The rat uterus inflammation is also had good inhibitory action, and the effect of capsule sheet is better than tablet.FUKE QIANJIN JIAONANG can be resisted the capillary permeability increase effect of acetic acid induced mice abdominal cavity, and the type blood deficiency mice that loses blood is had tangible blood tonification effect, can also resist the immune function of mice reduction that cyclophosphamide causes.Extracorporeal bacteria inhibitor test is the result show: to 9 kinds of antibacterials such as escherichia coli the clinical separation of totally 95 strains cause bacterium and have certain bacteriostasis.To the coli-infection mice, high dose has the certain protection effect, and the capsule effect slightly is better than tablet.
The clinical observe the curative effect of starting is as follows:
Through No. 1 Hospital Affiliated to Hunan Traditional Chinese Medical College, Hunan Province woman keep healthy institute, Hunan Province Affiliated Hospital of the academy of traditional Chinese medicine from March, 1998~1998 year November to 381 routine women's chronic pelvic inflammatory diseases, chronic endometritis, chronic cervicitis patient, adopt FUKE QIANJIN PIAN, FUKE QIANJIN JIAONANG, three kinds of medicines of JINJI PIAN to treat, test group (FUKE QIANJIN JIAONANG group) 161 examples wherein, matched group (FUKE QIANJIN PIAN group) 100 examples; Chronic palace intimitis 60 examples, wherein each 30 example of test group (women section a thousand pieces of gold Capsules group) and matched group (FUKE QIANJIN PIAN group); Chronic cervicitis 60 examples, wherein each 30 example of test group (FUKE QIANJIN JIAONANG group) and matched group (FUKE QIANJIN PIAN group).And with state of an illness integrated value judgement curative effect before and after the treatment.
The result shows: the total obvious effective rate of (1) FUKE QIANJIN JIAONANG treatment chronic pelvic inflammatory disease, total effective rate are respectively 80.12%, 98.75%; Treat the total obvious effective rate of chronic palace intimitis, total effective rate is respectively 100%, 100%; The total obvious effective rate of treatment chronic cervicitis, total effective rate are respectively 33.3%, 96.7%; Its determined curative effect is better than FUKE QIANJIN PIAN sheet group; The medicine of (2) two kinds of dosage forms all has the effect of heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, benefiting qi and nourishing blood, strong waist and nourishing kidney, and chronic pelvic inflammatory disease, chronic palace intimitis, chronic cervicitis patient are all had better curative effect.(3) FUKE QIANJIN JIAONANG is lacked than the QIANJIN PIAN consumption, and it is more convenient to take medicine, and welcome by patient and clinician; (4) FUKE QIANJIN JIAONANG drug safety is not seen toxic and side effects and untoward reaction in the observation process.
Clinical application shows: FUKE QIANJIN PIAN and capsule curative effect obviously are better than JINJI PIAN, and the capsule curative effect is better than FUKE QIANJIN PIAN.Really reach final goal of the present invention.

Claims (1)

1, a kind of FUKE QIANJIN JIAONANG is characterized in that: it is the raw material with following consumption, makes according to following method: raw material: the incorporation of Radix Angelicae Sinensis, Radix Codonopsis, Herba Andrographis and Fructus Zanthoxyli Dissiti respectively is 9% of medical material total amount; The incorporation of Radix Rosae Laevigatae, Caulis Spatholobi, Caulis Mahoniae and Radix Flemingiae Philippinensis respectively is 16% of a medical material total amount; Its method is: A, at first Radix Angelicae Sinensis is extracted with alcohol percolation method make clear paste; B, Herba Andrographis extracted with ethanol refluxing process make clear paste; C, Caulis Mahoniae, Fructus Zanthoxyli Dissiti decocting in water are extracted twice, after filtering the merging of both filtrates is made clear paste; D, Radix Flemingiae Philippinensis, Radix Rosae Laevigatae, Caulis Spatholobi, Radix Codonopsis decocting in water are extracted an after-filtration, the medicinal residues after filtering with the Radix Angelicae Sinensis medicinal residues of technology A and the Herba Andrographis slag decocting in water of technology B, are filtered, merging filtrate is also made clear paste; E, merge above-mentioned A, B, four kinds of clear paste of C, D, through mixing, spray drying, granulation, fill four procedures the finished product FUKE QIANJIN JIAONANG.
CNB99115682XA 1999-12-07 1999-12-07 Process for preparing 'Qianjin' capsule to treat genopathy Expired - Lifetime CN1170549C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB99115682XA CN1170549C (en) 1999-12-07 1999-12-07 Process for preparing 'Qianjin' capsule to treat genopathy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB99115682XA CN1170549C (en) 1999-12-07 1999-12-07 Process for preparing 'Qianjin' capsule to treat genopathy

Publications (2)

Publication Number Publication Date
CN1298730A CN1298730A (en) 2001-06-13
CN1170549C true CN1170549C (en) 2004-10-13

Family

ID=5278607

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB99115682XA Expired - Lifetime CN1170549C (en) 1999-12-07 1999-12-07 Process for preparing 'Qianjin' capsule to treat genopathy

Country Status (1)

Country Link
CN (1) CN1170549C (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100408070C (en) * 2005-04-14 2008-08-06 广西灵峰药业有限公司 Medicine for treating gynecopathy inflammation and its production method
US10329316B2 (en) 2016-03-17 2019-06-25 Qianjin Pharmaceutical Co., Ltd. Phenylpropanoid compound and preparation method and use thereof
US20220143125A1 (en) * 2018-11-14 2022-05-12 Qianjin Pharmaceutical Co., Ltd. Fuke qianjin capsule and quality control method therefor

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1330335C (en) * 2004-06-18 2007-08-08 株洲千金药业股份有限公司 Method for preparing a gynecopathy treating medicine
CN1318054C (en) * 2004-08-26 2007-05-30 仁和(集团)发展有限公司 Prepn process of medicine for treating gynecopathy
CN101347496B (en) * 2007-07-20 2011-10-05 天津天士力制药股份有限公司 Effective component of Spatholobus stem and preparation and use thereof
CN102552740B (en) * 2012-01-06 2013-09-11 刘梅 Chinese medicine for curing gynecological inflammations and preparation method thereof
CN102973739A (en) * 2012-12-06 2013-03-20 青岛文创科技有限公司 Traditional Chinese medicine composition for treating gynaecology chronic pelvic inflammatory disease
CN105012753A (en) * 2015-08-07 2015-11-04 张卉 Traditional Chinese medicine for treating acute endometritis and preparation method
CN109722931A (en) * 2017-10-31 2019-05-07 株洲千金药业股份有限公司 A kind of go to the lavatory towel and its method of the preparation of prescriptions worth thousand gold dregs of a decoction resource regeneration
CN109172677A (en) * 2018-11-14 2019-01-11 株洲千金药业股份有限公司 ' Qianjin ' capsule to treat ganopathy and preparation method thereof
CN109254098A (en) * 2018-11-14 2019-01-22 株洲千金药业股份有限公司 A kind of method of quality control of ' Qianjin ' capsule to treat ganopathy
CN109091567A (en) * 2018-11-14 2018-12-28 株洲千金药业股份有限公司 Application of the volatile oil part of gynaecology's prescriptions worth thousand gold or gynaecology's prescriptions worth thousand gold in preparation treatment fibroid drug
CN109364147A (en) * 2018-11-14 2019-02-22 株洲千金药业股份有限公司 A kind of ' Qianjin ' capsule to treat ganopathy and preparation method thereof
CN109568206B (en) * 2018-12-26 2022-07-19 株洲千金药业股份有限公司 Special antibacterial composition and lotion for women and preparation method thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100408070C (en) * 2005-04-14 2008-08-06 广西灵峰药业有限公司 Medicine for treating gynecopathy inflammation and its production method
US10329316B2 (en) 2016-03-17 2019-06-25 Qianjin Pharmaceutical Co., Ltd. Phenylpropanoid compound and preparation method and use thereof
US20220143125A1 (en) * 2018-11-14 2022-05-12 Qianjin Pharmaceutical Co., Ltd. Fuke qianjin capsule and quality control method therefor
US12144841B2 (en) * 2018-11-14 2024-11-19 Qianjin Pharmaceutical Co., Ltd. Fuke Qianjin Capsule and quality control method therefor

Also Published As

Publication number Publication date
CN1298730A (en) 2001-06-13

Similar Documents

Publication Publication Date Title
CN1170549C (en) Process for preparing 'Qianjin' capsule to treat genopathy
CN101843787B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843699B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN103285310A (en) Use of rhodiola rosea compound composition in preparing medicine for curing gastric ulcer
CN102284022A (en) Cough medicament and preparation method thereof
CN1158087C (en) Process for preparing 'Qianjin' capsule to treat ganopathy
CN101843804A (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN1351872A (en) Chinese herbal medicine for curing comedo and acne
CN102274353B (en) Traditional Chinese preparation for treating ulcers
CN101850071B (en) Chinese medicament for treating chronic nephritis
CN101129666A (en) Wild jujube beverage for soothing nerves
CN105125885B (en) It is a kind of to be used to prevent Chinese medicine composition of diabetes and preparation method thereof
CN100457147C (en) Chinese medicine composition for treating climacteric metancholia for women and preparing method thereof
CN101732539B (en) Medicament for treating gynecological diseases and preparation method thereof
CN101850020B (en) Chinese medicament for treating chronic kidney failure
CN101884747B (en) Traditional Chinese medicine for treating chronic nephritis
CN101843693A (en) Chinese medicament for treating diabetic nephropathy
CN100353987C (en) Chinese medicinal preparation for treating acne
CN101259165A (en) Chaihuang preparations and producing method thereof
CN101085185A (en) Beverage containing white peony root and gardenia
CN101129830B (en) Medicine for treating urinary system affection and method of preparing the same
CN104147202B (en) Benefiting qi and nourishing blood, toxin expelling Fructus Alpiniae Oxyphyllae, Yin Yang balancing, the microcirculatory compositions of improvement and preparation thereof
CN1314175A (en) Traditional Chinese medicine composition for curing insomnia
CN101843833B (en) Chinese medicament for treating diabetic nephropathy
CN101843695B (en) Chinese medicament for treating chronic kidney failure

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term

Granted publication date: 20041013

CX01 Expiry of patent term